Reasons for testing and clinical and demographic profile of adolescents with non-perinatally acquired HIV infection

Pediatrics
Althea M GrantSheryl L Henderson

Abstract

We sought to examine the demographic, clinical, and behavioral characteristics; reasons for HIV testing; and factors that contribute to delays in entry into specialized HIV care after diagnosis of HIV infection among adolescents in an urban clinic in Georgia. All of the data for this study were obtained solely by medical chart review. Demographic, clinical, behavioral, and HIV testing data were abstracted from medical charts of 59 non-perinatally HIV-infected adolescents who were aged 13 to 18 years and entered care at the pediatric and adolescent HIV clinic of a Georgia hospital during 1999-2002. HIV-infected adolescents were compared by demographic, clinical, and behavioral characteristics as well as by circumstances surrounding HIV testing. Recent seroconversion was defined as having a documented negative or indeterminate HIV antibody test (confirmed) or a self-reported negative HIV test (probable) < or =6 months before HIV diagnosis. Of 59 HIV-infected adolescents, 35 (59%) were female and 56 (95%) were black/African American. Fifteen (25%) had > or =1 sexually transmitted infection when they entered care. All female (vs 38% male) adolescents were infected through heterosexual sexual intercourse; 9 (26%) were pregnant at th...Continue Reading

References

Apr 1, 1996·American Journal of Public Health·M Males, K S Chew
Aug 15, 1996·Annals of Internal Medicine·T SchackerL Corey
Jun 1, 1996·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·C FullerS E Abdalian
Nov 1, 1995·International Journal of STD & AIDS·T G HeckmanL Y Stevenson
Aug 1, 1997·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·L R ClarkL J D'Angelo
Jul 2, 1998·The New England Journal of Medicine·J O Kahn, B D Walker
Dec 22, 1999·AIDS·R O ValdiserriG R West
Oct 24, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Scott E KellermanPascale M Wortley
Jul 31, 2003·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Douglas N BellCarl Siciliano
Oct 3, 2003·Pediatrics·Mridula Aggarwal, Jeffrey Rein
Nov 15, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Joan S TuckerDaniela Golinelli
Mar 31, 2004·Obstetrics and Gynecology·Janet M BlairMark S Dworkin
May 4, 2004·The Journal of Infectious Diseases·Christopher D PilcherUNKNOWN Duke-UNC-Emory Acute HIV Consortium
Apr 6, 2005·The Journal of Infectious Diseases·Maria J WawerThomas C Quinn

❮ Previous
Next ❯

Citations

Apr 11, 2009·Current HIV/AIDS Reports·Hans M L Spiegel, Donna C Futterman
Sep 25, 2012·HIV Medicine·A HughesF Boag
Oct 9, 2008·BMC Infectious Diseases·Judy E MillSusan Sommerfeldt
Feb 22, 2013·Pediatric Emergency Care·Clare M HackMichael D Rosen
Mar 23, 2010·The Journal of the Association of Nurses in AIDS Care : JANAC·Karolynn SiegelNancy VanDevanter
Aug 23, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Christian ThurstoneSusan K Mikulich-Gilbertson
May 7, 2010·Perspectives on Sexual and Reproductive Health·Shayna D CunninghamJonathan M Ellen
Jul 22, 2006·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Audrey Smith Rogers
May 15, 2012·International Journal of STD & AIDS·T K MullinsJ A Kahn
Oct 17, 2019·Research and Theory for Nursing Practice·Oluwamuyiwa Winifred Adebayo, John P Salerno
Jul 17, 2010·AIDS Care·Catherine WorthingtonSusan Sommerfeldt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Scott E KellermanPascale M Wortley
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
Renata Arrington-Sanders, Jonathan Ellen
AIDS Patient Care and STDs
Ligia PeraltaKareem Ghalib
© 2021 Meta ULC. All rights reserved